PLAYSTUDIOS, Inc. current report, 18 September 2026

Business Context and Reporting Period

PLAYSTUDIOS, Inc. filed this Form 8-K on September 18, 2026, regarding the planned cessation of its sweepstakes product, The Win Zone. The decision is expected to affect the third quarter of 2026, ending September 30, 2026.

Financial Impact

  • Impairment charge: The Company expects to recognize a pre-tax impairment charge of approximately $3.0 million to $3.5 million.
  • Asset category: The charge relates primarily to capitalized internal-use software associated with The Win Zone.
  • Basis: Management determined that the assets’ useful lives should be reduced and that their carrying value was not recoverable under U.S. GAAP.
  • Tax impact: The potential impact on income tax expense has not been finalized.
  • The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.

Material Changes and Unusual Items

The planned discontinuation of The Win Zone represents a material change in the Company’s product operations and triggered an impairment indicator during the third quarter of 2026. The filing does not provide a comparable prior-period impairment amount or quantify the product’s historical financial contribution.

Guidance, Outlook, Risks, and Contingencies

  • Management expects to complete its assessment and finalize the impairment charge and related tax effects in the Form 10-Q for the quarter ending September 30, 2026.
  • The final impairment amount may differ from the preliminary range of $3.0 million to $3.5 million.
  • The filing does not provide broader earnings guidance or an updated outlook.

Investor Verification Items

  • Verify the final impairment amount and related tax expense in the third-quarter 2026 Form 10-Q.
  • Assess the effect of ceasing The Win Zone on future revenue, operating expenses, cash flow, and segment or product performance.
  • Review whether additional restructuring, shutdown, contractual, or other exit costs are disclosed in subsequent filings.
  • Determine whether the impairment affects covenants, liquidity, or the carrying value of other related assets.